Chinmay-Raj Bio-Tech Private Limited
Founded in 1994 and headquartered in Gujarat, India.
1994 | Ahmedabad, Gujarat (India) | Active
Chinmay-Raj Bio-Tech Profile
Key Indicators
- Authorised Capital ₹ 0.40 M
- Paid Up Capital ₹ 0.20 M
- Company Age 30 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -41.89%
- Profit Growth -35.36%
- Ebitda -9.12%
- Net Worth 1.36%
- Total Assets 20.79%
About Chinmay-Raj Bio-Tech
Chinmay-Raj Bio-Tech Private Limited (CBPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 June 1994 and has a history of 30 years and eight months. Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.40 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Swati Mehta and Renuka Sheth serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24231GJ1994PTC022229
- Company No.
022229
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Jun 1994
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Trading
Who are the key members and board of directors at Chinmay-Raj Bio-Tech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Swati Mehta  | Director | 09-Jun-1994 | Current |
| Renuka Sheth | Director | 09-Jun-1994 | Current |
Financial Performance of Chinmay-Raj Bio-Tech.
Chinmay-Raj Bio-Tech Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 41.89% decrease. The company also saw a substantial fall in profitability, with a 35.36% decrease in profit. The company's net worth moved up by a moderate rise of 1.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chinmay-Raj Bio-Tech?
In 2017, Chinmay-Raj Bio-Tech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Ceramig Minerals Llp
Swati Mehta is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Chinmay-Raj Bio-Tech?
Unlock and access historical data on people associated with Chinmay-Raj Bio-Tech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chinmay-Raj Bio-Tech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chinmay-Raj Bio-Tech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.